Summit Research Network

What Summit Research Network does

Summit Research Network is a private, Phase II–IV clinical research site headquartered in Portland, Oregon, that has been conducting industry-sponsored clinical trials since 1976. The organization executes contracted research services for pharmaceutical and biotech sponsors, enrolling participants across eight active therapeutic areas: ADHD, Alzheimer's disease and memory loss, depression, diabetes, migraine, weight loss and obesity, vaccines, and generalized anxiety disorder. A specialized Memory Health Center sub-brand focuses on dementia and age-related cognitive conditions, including cognitive assessments and memory evaluations. Service delivery is performed by a multidisciplinary staff of physicians, psychologists, nurse practitioners, certified clinical research coordinators, medical assistants, and research raters, with two principal investigators alone carrying between 60 and 250+ lifetime clinical trials each.

The company's business model is a professional services revenue stream earned from sponsor contracts. Studies are conducted under double-blind and monitored designs, with participant care, study-related evaluations, and professional supervision delivered at no cost to qualifying participants (no health insurance required), with stipends often provided for time and travel. Participant recruitment relies on a hybrid commercial motion: digital channels (Facebook, Instagram, LinkedIn, Google Search), traditional out-of-home advertising (billboards, bus stops, radio, TV, newspaper, flyers), and a community referral layer from existing participants and healthcare providers. The site describes its segment mix as a hybrid of individual patient recruitment and sponsor-facing enrollment services, with primary demand-pull coming from pharmaceutical companies seeking high-quality sites for regulatory-grade trial execution.

In 2021, Summit Research joined the Headlands Research integrated network of clinical trials sites, becoming a subsidiary within a larger strategic operator while retaining local operational autonomy. The organization operates from a single headquarters location (2701 NW Vaughn St., Suite 350, Portland, OR 97210), has 11–50 employees, and maintains no app products, public APIs, or disclosed patents. No technology platform, AI tooling, or proprietary software product is described in the source data beyond conventional clinical trial management infrastructure.

Name

Summit Research Network

Legal name

Summit Research Network

Website

https://summitresearchnetwork.com

Company type

Private

Founded year

1976

Operating status

Operating

Headcount range

11–50 employees

Short description

Summit Research Network is a Portland, Oregon-based Phase II–IV clinical research site operating since 1976, conducting industry-sponsored trials across eight therapeutic areas for pharmaceutical sponsors while recruiting participants through direct community outreach.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Health Services (8000)

akta.pro primary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

akta.pro secondary industry

Clinical Development (Phase I–III Trial Design & Execution) (HLAIALAE)

Keywords

• Clinical research services
• Clinical trial site
• Phase II-IV trials
• Investigational medication trials
• Pharmaceutical clinical research

Headquarters

HQ city

Portland

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Clinical Research Services: Summit Research conducts clinical trials on behalf of pharmaceutical companies, earning revenue through contracted research services. They provide study-related care, evaluations, and supervision by professional staff. Many trials provide stipends or compensation for participant time and travel.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Core offering

Summit Research Network operates as a clinical trial site that conducts Phase II–IV studies for pharmaceutical sponsors across eight therapeutic areas: ADHD, Alzheimer's Disease/Memory Loss, Depression, Diabetes, Migraine, Weight Loss & Obesity, Vaccines, and Generalized Anxiety Disorder. The organization recruits qualified participants, delivers study-related medical care, evaluations, and physician supervision, and provides an on-site Memory Health Center for dementia and age-related memory conditions. Services are provided at no cost to qualifying participants, with no health insurance required, and many trials offer stipends for time and travel.

Product overview

Summit Research Network is a clinical research organization that has been conducting clinical trials since 1976. The company operates as a unified clinical research platform offering investigational medication trials across eight therapeutic areas: ADHD, Alzheimer's Disease/Memory Loss, Depression, Diabetes, Migraine, Weight Loss & Obesity, Vaccines, and Generalized Anxiety Disorder. The company also provides a specialized Memory Health Center for dementia and age-related memory conditions. All services include comprehensive participant care, evaluations, and professional staff supervision, with services provided at no cost to qualifying participants.

Differentiator

Problem solved

Functional benefit

Brands

• Memory Health Center: Specialized center within Summit Research Network focusing on dementia and age-related memory conditions.

Products and services

• ADHD Clinical Trials Clinical research studies evaluating investigational medications and treatments for Attention Deficit Hyperactivity Disorder (ADHD), offered to qualified participants in the Portland, Oregon metro area at no cost.
• Alzheimer's Disease / Memory Loss Research Clinical trials focused on Alzheimer's disease and other memory-related conditions, including IV medications and dementia studies, offered to qualified participants at no cost.
• Depression Clinical Trials Clinical research studies evaluating new antidepressant treatments, including studies for Major Depressive Disorder (MDD) and treatment-resistant depression, provided at no cost to qualifying participants.
• Diabetes Clinical Trials Clinical research studies evaluating treatments and medications for diabetes management, provided to qualifying participants at no cost.
• Migraine Clinical Trials Clinical research studies evaluating treatments for migraines and headaches, provided to qualifying participants at no cost.
• Weight Loss & Obesity Research Clinical trials evaluating investigational medications and treatments for weight loss and obesity management, provided to qualifying participants at no cost.
• Vaccine Clinical Trials Clinical research studies evaluating vaccine candidates and immunizations, provided to qualifying participants at no cost.
• Generalized Anxiety Disorder Research Clinical research studies evaluating treatments for generalized anxiety disorder, provided to qualifying participants at no cost.
• Memory Health Center Specialized service within Summit Research focused on dementia and other age-related memory conditions, offering cognitive assessments and memory evaluations as part of clinical trial participant evaluation.
• Clinical Research Participant Services Comprehensive participant care including medical evaluations, study-related care, supervision by professional staff, and post-study treatment programs, provided at no cost to qualifying clinical trial participants with no health insurance required.

Quantifiable outcome

• Clinical trials provided at no cost to participants; no health insurance required

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Headlands ResearchcoreStrategic or Co-development Partner · 1 January 2021In 2021, Summit Research joined Headlands Research integrated network of clinical trials sites. Headlands Research is a network of clinical trial sites that provides operational support, infrastructure, and resources to enhance clinical research capabilities. This integration provides Summit Research with the scale and resources of a larger organization while maintaining local operational excellence in the Portland, Oregon area.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Medpace: Medpace is a mid-to-large global CRO with full-service clinical trial capabilities. Comparable as a competitor for sponsor clinical trial outsourcing decisions, though operating as a CRO rather than a dedicated site network.
• ICON plc: ICON plc is a large global CRO with extensive CNS clinical trial experience and site relationships. Comparable as a broad incumbent competing for pharmaceutical CNS and multi-therapeutic trial outsourcing.
• IQVIA: IQVIA is the largest global CRO with substantial site management and clinical operations services. Relevant as a broad incumbent competing for the same sponsor clinical trial work, though at much larger scale and across all therapeutic areas.
• Syneos Health: Syneos Health is a fully integrated biopharmaceutical solutions organization offering clinical development and site management services. Comparable as a broad incumbent CRO/SMO competitor for sponsor clinical trial awards.
• Headlands Research: Headlands Research is Summit Research Network's parent company — an integrated network of clinical trial sites. Relevant as the controlling entity and as the broader SMO platform in which Summit sits, providing comparable network-level scale and strategy.
• Charles River Laboratories: Charles River Laboratories provides preclinical and clinical research services including site partnerships. Relevant incumbent comparator in the broader clinical research services landscape, though with a different core focus on preclinical and discovery.

Direct peers

• CenExel Clinical Research: CenExel is a multi-site clinical research network operating dedicated research centers across CNS, pain, and other therapeutic areas. Highly comparable to Summit Research Network as a specialized SMO competing for the same sponsor CNS trial volume.
• Accel Research Sites: Accel Research Sites is a multi-therapeutic SMO network conducting Phase II-IV trials across CNS, vaccines, dermatology, and general medicine. Closely comparable in scope, therapeutic mix, and site-network business model.
• Velocity Clinical Research: Velocity operates one of the largest integrated SMO networks in the US, with multi-therapeutic capability including CNS and general medicine trials. Direct competitor for multi-site pharmaceutical contracts and a benchmark for scaled SMO operations.
• JBR Clinical Research: JBR Clinical Research is a Utah-based SMO running multi-therapeutic clinical trials including CNS, vaccines, and general medicine. Comparable as a regional SMO with similar trial portfolio and sponsor relationship model.

Market position

Strengths5 records

Weaknesses1 record

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/summitresearch
• Facebookfacebook.com/SummitResearch
• LinkedInlinkedin.com/company/summit-research

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Summit Research Network